市場調查報告書 - 217230

糖尿病腎病變:全球臨床實驗回顧(2011年下半年)

Diabetic Nephropathy Global Clinical Trials Review, H2, 2011
出版商 GlobalData
出版日期 2011年09月30日 內容資訊 英文 Pages: 99
價格
糖尿病腎病變:全球臨床實驗回顧(2011年下半年) Diabetic Nephropathy Global Clinical Trials Review, H2, 2011
出版日期: 2011年09月30日 內容資訊: 英文 Pages: 99
簡介

本報告提供糖尿病腎病變治療藥物的臨床實驗資料，彙整各國的趨勢，臨床實驗數，全球各臨床實驗中心的募集情形等資料，為您概述為以下內容。

目錄

簡介

  • 糖尿病腎病變
  • 關於本報告

不同地區的臨床實驗

  • 各國臨床實驗
    • 亞太地區的前五名國家
    • 歐洲的前五名國家
    • 北美前幾名國家
    • 中東及非洲的前五名國家
    • 中南美的前五名國家

金磚四國的臨床實驗

G7各國的臨床實驗

各進展狀況:G7各國的臨床實驗

E7各國的臨床實驗

各進展狀況:E7各國的臨床實驗

各方面的臨床實驗

各進展狀況的臨床實驗

尚未完成的臨床實驗

一定期間內採用的實驗人數

有潛力的贊助商

有潛力的藥劑比較

臨床實驗簡介

  • 臨床實驗概要:前幾名企業
    • Pfizer Inc
    • Eli Lilly and Company
    • Novartis AG
    • Abbott Laboratories
    • Keryx Biopharmaceuticals, Inc
    • FibroGen, Inc
    • Johnson & Johnson
    • Boehringer Ingelheim GmbH
    • Daiichi Sankyo Company, Ltd
    • Synvista Therapeutics, Inc
    • XTL Biopharmaceuticals Ltd
    • Reata Pharmaceuticals, Inc
    • BioStratum, Inc
    • Angelini Group
    • PhytoHealth Corporation
    • Sankyo Co, Ltd
    • MannKind Corporation
    • Vernalis plc
    • Bayer AG
    • NephroGenex, Inc
  • 臨床實驗概要:前幾名大學·研究所·醫院
    • The National Institute of Diabetes and Digestive and Kidney Diseases
    • Shanghai Jiao Tong University
    • Steno Diabetes Center A/S
    • Kanazawa Medical University
    • Okayama University
    • US Department of Veterans Affairs
    • Chinese University of Hong Kong
    • University of Washington
    • Nanjing Medical University
    • Shiraz University of Medical Sciences
    • Tehran University of Medical Sciences
    • Yokohama City University
    • Holstebro Hospital
    • The University of Texas Health Science Center at San Antonio
    • AHEPA University Hospital
    • Sheba Medical Center
    • Assaf-Harofeh Medical Center
    • Karolinska Institutet
    • Texas Tech University Health Sciences Center
    • Stanford University

主要的臨床簡介

附錄

圖表一覽

目錄

Abstract

Summary

GlobalData's clinical trial report, "Diabetic Nephropathy Global Clinical Trials Review, H2, 2011" provides data on the Diabetic Nephropathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diabetic Nephropathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Diabetic Nephropathy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents
  • Table of Contents
  • List of Tables
  • List of Figures
  • Introduction
    • Diabetic Nephropathy
    • Report Guidance
  • Clinical Trials by Region
  • Clinical Trials by Country
    • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
    • Top Five Countries Contributing to Clinical Trials in Europe
    • Top Countries Contributing to Clinical Trials in North America
    • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
    • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by BRIC Nations
  • Clinical Trials by G7 Nations
  • Clinical Trials in G7 Nations by Trial Status
  • Clinical Trials by E7 Nations
  • Clinical Trials in E7 Nations by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Unaccomplished Trials of Diabetic Nephropathy
  • Subjects Recruited Over a Period of Time
  • Prominent Sponsors
    • Top Companies Participating in Diabetic Nephropathy Therapeutics Clinical Trials
  • Prominent Drug Comparison
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
    • Pfizer Inc.
    • Clinical Trial Overview of Pfizer Inc.
    • Eli Lilly and Company
    • Clinical Trial Overview of Eli Lilly and Company
    • Novartis AG
    • Clinical Trial Overview of Novartis AG
    • Abbott Laboratories
    • Clinical Trial Overview of Abbott Laboratories
    • Keryx Biopharmaceuticals, Inc.
    • Clinical Trial Overview of Keryx Biopharmaceuticals, Inc.
    • FibroGen, Inc.
    • Clinical Trial Overview of FibroGen, Inc.
    • Johnson & Johnson
    • Clinical Trial Overview of Johnson & Johnson
    • Boehringer Ingelheim GmbH
    • Clinical Trial Overview of Boehringer Ingelheim GmbH
    • Daiichi Sankyo Company, Ltd
    • Clinical Trial Overview of Daiichi Sankyo Company, Ltd.
    • Synvista Therapeutics, Inc.
    • Clinical Trial Overview of Synvista Therapeutics, Inc.
    • XTL Biopharmaceuticals Ltd.
    • Clinical Trial Overview of XTL Biopharmaceuticals Ltd.
    • Reata Pharmaceuticals, Inc.
    • Clinical Trial Overview of Reata Pharmaceuticals, Inc.
    • BioStratum, Inc.
    • Clinical Trial Overview of BioStratum, Inc.
    • Angelini Group
    • Clinical Trial Overview of Angelini Group
    • PhytoHealth Corporation
    • Clinical Trial Overview of PhytoHealth Corporation
    • Sankyo Co., Ltd.
    • Clinical Trial Overview of Sankyo Co., Ltd.
    • MannKind Corporation
    • Clinical Trial Overview of MannKind Corporation
    • Vernalis plc
    • Clinical Trial Overview of Vernalis plc
    • Bayer AG
    • Clinical Trial Overview of Bayer AG
    • NephroGenex, Inc.
    • Clinical Trial Overview of NephroGenex, Inc.
  • Clinical Trial Overview of Top Universities / Institutes / Hospitals
    • The National Institute of Diabetes and Digestive and Kidney Diseases
    • Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases
    • Shanghai Jiao Tong University
    • Clinical Trial Overview of Shanghai Jiao Tong University
    • Steno Diabetes Center A/S
    • Clinical Trial Overview of Steno Diabetes Center A/S
    • Kanazawa Medical University
    • Clinical Trial Overview of Kanazawa Medical University
    • Okayama University
    • Clinical Trial Overview of Okayama University
    • U.S. Department of Veterans Affairs
    • Clinical Trial Overview of U.S. Department of Veterans Affairs
    • Chinese University of Hong Kong
    • Clinical Trial Overview of Chinese University of Hong Kong
    • University of Washington
    • Clinical Trial Overview of University of Washington
    • Nanjing Medical University
    • Clinical Trial Overview of Nanjing Medical University
    • Shiraz University of Medical Sciences
    • Clinical Trial Overview of Shiraz University of Medical Sciences
    • Tehran University of Medical Sciences
    • Clinical Trial Overview of Tehran University of Medical Sciences
    • Yokohama City University
    • Clinical Trial Overview of Yokohama City University
    • Holstebro Hospital
    • Clinical Trial Overview of Holstebro Hospital
    • The University of Texas Health Science Center at San Antonio
    • Clinical Trial Overview of the University of Texas Health Science Center at San Antonio
    • AHEPA University Hospital
    • Clinical Trial Overview of AHEPA University Hospital
    • Sheba Medical Center
    • Clinical Trial Overview of Sheba Medical Center
    • Assaf-Harofeh Medical Center
    • Clinical Trial Overview of Assaf-Harofeh Medical Center
    • Karolinska Institutet
    • Clinical Trial Overview of Karolinska Institutet
    • Texas Tech University Health Sciences Center
    • Clinical Trial Overview of Texas Tech University Health Sciences Center
    • Stanford University
    • Clinical Trial Overview of Stanford University
  • Key Clinical Profiles

Appendix

  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About GlobalData
  • Contact Us
  • Disclaimer
  • Source

List of Tables
  • Diabetic Nephropathy Therapeutics Market, Global, Clinical Trials by Zone, 2011*
  • Diabetic Nephropathy Therapeutics Market, Global, Clinical Trials by Top Countries, 2011*
  • Diabetic Nephropathy Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials, North America, Top Countries, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials, BRIC Countries, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials, G7 Countries, 2011*
  • Diabetic Nephropathy Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials, E7 Countries, 2011*
  • Diabetic Nephropathy Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2011*
  • Diabetic Nephropathy Therapeutics Market, Global, Clinical Trials by Phase, 2011*
  • Diabetic Nephropathy Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011*
  • Diabetic Nephropathy Therapeutics Market, Global, Clinical Trials by Trial Status, 2011*
  • Diabetic Nephropathy Therapeutics Market, Global, Withdrawn Clinical Trials, 2011*
  • Diabetic Nephropathy Therapeutics Market, Global, Terminated Clinical Trials, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
  • Diabetic Nephropathy Therapeutics Clinical Trials, Global, Key Sponsors, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Keryx Biopharmaceuticals, Inc., 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by FibroGen, Inc., 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim GmbH, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Ltd, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Synvista Therapeutics, Inc., 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by XTL Biopharmaceuticals Ltd., 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Reata Pharmaceuticals, Inc., 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by BioStratum, Inc., 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Angelini Group, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by PhytoHealth Corporation, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Sankyo Co., Ltd., 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by MannKind Corporation, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Vernalis plc, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by NephroGenex, Inc., 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Shanghai Jiao Tong University, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Steno Diabetes Center A/S, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Kanazawa Medical University, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Okayama University, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Nanjing Medical University, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiraz University of Medical Sciences, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Yokohama City University, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Holstebro Hospital, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas Health Science Center at San Antonio, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by AHEPA University Hospital, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Sheba Medical Center, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Assaf-Harofeh Medical Center, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Karolinska Institutet, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Texas Tech University Health Sciences Center, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2011*

List of Figures
  • Diabetic Nephropathy Therapeutics Market, Global, Clinical Trials by Zone (%), 2011*
  • Diabetic Nephropathy Therapeutics Market, Global, Clinical Trials by Top Countries, 2011*
  • Diabetic Nephropathy Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials, North America, Top Countries (%), 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials, BRIC Countries (%), 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials, G7 Countries (%), 2011*
  • Diabetic Nephropathy Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials, E7 Countries (%), 2011*
  • Diabetic Nephropathy Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2011*
  • Diabetic Nephropathy Therapeutics Market, Global, Clinical Trials by Phase (%), 2011*
  • Diabetic Nephropathy Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011*
  • Diabetic Nephropathy Therapeutics Market, Global, Clinical Trials by Trial Status, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
  • Diabetic Nephropathy Therapeutics Clinical Trials, Global, Key Sponsors, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011*
  • Diabetic Nephropathy Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011*
  • GlobalData Methodology

糖尿病腎病變:全球臨床實驗回顧(2011年下半年)是由出版商GlobalData在2011年09月30日所出版的。這份市場調查報告書包含Pages: 99 價格從美金1000起跳。
Back to Top
;